CARIS MOLECULAR TUMOR BOARD REPORT Trademark
CARIS MOLECULAR TUMOR BOARD REPORT is a USPTO trademark filed by Caris MPI, Inc.. Status: Pending.
Trademark Facts
| Mark | CARIS MOLECULAR TUMOR BOARD REPORT |
|---|---|
| Serial Number | 99701203 |
| Status | Pending |
| Filing Date | 2026-03-13 |
| Mark Type | Combined |
| Nice Classes | 042 (Software & IT), 044 (Medical Services) |
| Owner | Caris MPI, Inc. |
| Attorney of Record | Anne C. Fleeson |
| Prosecution Events | 2 |
| Latest Event | MAFR on 2026-03-13 |
Goods & Services
Class 042: Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on molecular profiling, including next-generation sequencing (NGS) such as whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS); Class 044: Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer using bioinformatics and artificial intelligence; providing medical information in the field of cancer based on molecular profiling, including next-generation sequencing (NGS) such as whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)